Post-PCI Risk Assessment by Inflammation Activity According to Disease Acuity and Time from Procedure.

Haegeun SongJong-Hwa AhnMin Gyu KangKye Hwan KimJae Seok BaeSang-Yeong ChoJin Sin KohYongwhi ParkSeok-Jae HwangEun Jeong ChoKyeongmin ByeonSang-Wook KimUdaya S TantryPaul A GurbelJin-Yong HwangYoung Hoon Jeong

Published in: Thrombosis and haemostasis (2023)

AMI patients have greater inflammation during the early and late phases than non-AMI patients. Risk phenotype of hsCRPbaseline correlates with 1-month outcomes only in AMI patients. Whereas the prognostic implication of this risk phenotype appears similar during the late phase, irrespective of the disease acuity.

Keyphrases

end stage renal disease
risk assessment
ejection fraction
newly diagnosed
acute myocardial infarction
chronic kidney disease
oxidative stress
peritoneal dialysis
prognostic factors
heart failure
type diabetes
coronary artery disease
adipose tissue
heavy metals
minimally invasive
human health
insulin resistance